https://stock.noler.com/us/stock/sierra-oncology-inc https://stock.noler.com/us/stock/sierra-oncology-inc/accounts-payable https://stock.noler.com/us/stock/sierra-oncology-inc/accrual-carrying-value-payments https://stock.noler.com/us/stock/sierra-oncology-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/sierra-oncology-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/accrued-liabilities-current https://stock.noler.com/us/stock/sierra-oncology-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/sierra-oncology-inc/accumulated-depreciation https://stock.noler.com/us/stock/sierra-oncology-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/sierra-oncology-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/sierra-oncology-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sierra-oncology-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sierra-oncology-inc/amended-reports-10-k https://stock.noler.com/us/stock/sierra-oncology-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/sierra-oncology-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sierra-oncology-inc/aoci https://stock.noler.com/us/stock/sierra-oncology-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/sierra-oncology-inc/available-for-sale-current https://stock.noler.com/us/stock/sierra-oncology-inc/capital-expenditures https://stock.noler.com/us/stock/sierra-oncology-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/sierra-oncology-inc/capital-units-authorized https://stock.noler.com/us/stock/sierra-oncology-inc/cash https://stock.noler.com/us/stock/sierra-oncology-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/sierra-oncology-inc/cash-and-equivalents https://stock.noler.com/us/stock/sierra-oncology-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sierra-oncology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sierra-oncology-inc/cash-uninsured-amount https://stock.noler.com/us/stock/sierra-oncology-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/sierra-oncology-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/sierra-oncology-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/sierra-oncology-inc/commitments-and-contingencies https://stock.noler.com/us/stock/sierra-oncology-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/sierra-oncology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sierra-oncology-inc/common-stock-value https://stock.noler.com/us/stock/sierra-oncology-inc/comprehensive-income https://stock.noler.com/us/stock/sierra-oncology-inc/contractual-obligation https://stock.noler.com/us/stock/sierra-oncology-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/sierra-oncology-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/sierra-oncology-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/sierra-oncology-inc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/sierra-oncology-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/sierra-oncology-inc/convertible-notes-payable https://stock.noler.com/us/stock/sierra-oncology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sierra-oncology-inc/current-assets https://stock.noler.com/us/stock/sierra-oncology-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/current-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/sierra-oncology-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/debt-carrying-amount https://stock.noler.com/us/stock/sierra-oncology-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/sierra-oncology-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/sierra-oncology-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/sierra-oncology-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-offering-costs https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-revenue https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sierra-oncology-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/sierra-oncology-inc/depreciation https://stock.noler.com/us/stock/sierra-oncology-inc/depreciation-and-amortization https://stock.noler.com/us/stock/sierra-oncology-inc/derivative-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/derivative-liabilities-current https://stock.noler.com/us/stock/sierra-oncology-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/sierra-oncology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sierra-oncology-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/sierra-oncology-inc/effective-tax-rate https://stock.noler.com/us/stock/sierra-oncology-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/sierra-oncology-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/sierra-oncology-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-settlements https://stock.noler.com/us/stock/sierra-oncology-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/sierra-oncology-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/financing-cash-flow https://stock.noler.com/us/stock/sierra-oncology-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/sierra-oncology-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/sierra-oncology-inc/foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sierra-oncology-inc/foreign-pretax-income https://stock.noler.com/us/stock/sierra-oncology-inc/form-d-other https://stock.noler.com/us/stock/sierra-oncology-inc/form-d-stocks https://stock.noler.com/us/stock/sierra-oncology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sierra-oncology-inc/income-tax https://stock.noler.com/us/stock/sierra-oncology-inc/income-taxes-paid https://stock.noler.com/us/stock/sierra-oncology-inc/income-taxes-receivable https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sierra-oncology-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/sierra-oncology-inc/insider-transactions-other https://stock.noler.com/us/stock/sierra-oncology-inc/insider-transactions-preferred https://stock.noler.com/us/stock/sierra-oncology-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sierra-oncology-inc/insider-transactions-warrants https://stock.noler.com/us/stock/sierra-oncology-inc/interest-expense https://stock.noler.com/us/stock/sierra-oncology-inc/interest-expense-on-debt https://stock.noler.com/us/stock/sierra-oncology-inc/interest-paid https://stock.noler.com/us/stock/sierra-oncology-inc/interest-paid-net https://stock.noler.com/us/stock/sierra-oncology-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/sierra-oncology-inc/investing-cash-flow https://stock.noler.com/us/stock/sierra-oncology-inc/lease-cost https://stock.noler.com/us/stock/sierra-oncology-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sierra-oncology-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sierra-oncology-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/sierra-oncology-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/sierra-oncology-inc/level-3-liability-issues https://stock.noler.com/us/stock/sierra-oncology-inc/loans-payable-to-bank-current https://stock.noler.com/us/stock/sierra-oncology-inc/long-term-debt https://stock.noler.com/us/stock/sierra-oncology-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/sierra-oncology-inc/long-term-notes-payable https://stock.noler.com/us/stock/sierra-oncology-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/sierra-oncology-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sierra-oncology-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sierra-oncology-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sierra-oncology-inc/net-change-in-cash https://stock.noler.com/us/stock/sierra-oncology-inc/net-income https://stock.noler.com/us/stock/sierra-oncology-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/sierra-oncology-inc/number-of-operating-segments https://stock.noler.com/us/stock/sierra-oncology-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/sierra-oncology-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/sierra-oncology-inc/operating-cash-flow https://stock.noler.com/us/stock/sierra-oncology-inc/operating-expenses https://stock.noler.com/us/stock/sierra-oncology-inc/operating-income https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-assets https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-cost https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-liability https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sierra-oncology-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sierra-oncology-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sierra-oncology-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/sierra-oncology-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/sierra-oncology-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/sierra-oncology-inc/other-current-assets https://stock.noler.com/us/stock/sierra-oncology-inc/other-current-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/other-income https://stock.noler.com/us/stock/sierra-oncology-inc/other-noncash-income-expense https://stock.noler.com/us/stock/sierra-oncology-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sierra-oncology-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/sierra-oncology-inc/other-receivables-net-current https://stock.noler.com/us/stock/sierra-oncology-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/sierra-oncology-inc/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/sierra-oncology-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/sierra-oncology-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/sierra-oncology-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/sierra-oncology-inc/paid-in-kind-interest https://stock.noler.com/us/stock/sierra-oncology-inc/patents-active https://stock.noler.com/us/stock/sierra-oncology-inc/patents-pending https://stock.noler.com/us/stock/sierra-oncology-inc/patents-rejected https://stock.noler.com/us/stock/sierra-oncology-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sierra-oncology-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-shares-facts https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-amount-of-preferred-dividends-in-arrears https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-redemption-amount https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sierra-oncology-inc/preferred-stock-value https://stock.noler.com/us/stock/sierra-oncology-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sierra-oncology-inc/prepaid-insurance https://stock.noler.com/us/stock/sierra-oncology-inc/pretax-income https://stock.noler.com/us/stock/sierra-oncology-inc/pretax-income-domestic https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-repayment-of-loans-to-purchase-common-stock https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/sierra-oncology-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/sierra-oncology-inc/profit-loss https://stock.noler.com/us/stock/sierra-oncology-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sierra-oncology-inc/property-plant-equipment https://stock.noler.com/us/stock/sierra-oncology-inc/public-float https://stock.noler.com/us/stock/sierra-oncology-inc/realized-gains-on-securities https://stock.noler.com/us/stock/sierra-oncology-inc/research-and-development https://stock.noler.com/us/stock/sierra-oncology-inc/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/sierra-oncology-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/sierra-oncology-inc/restructuring-charges https://stock.noler.com/us/stock/sierra-oncology-inc/restructuring-reserve-current https://stock.noler.com/us/stock/sierra-oncology-inc/retained-earnings https://stock.noler.com/us/stock/sierra-oncology-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/sierra-oncology-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/sierra-oncology-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/sierra-oncology-inc/sec-comment-letters-drsltr https://stock.noler.com/us/stock/sierra-oncology-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-10-k https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-10-q https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-15-12g https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-25-nse https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-8-k https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-certnas https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-ct-order https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-def-14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-defa14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-defm14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-no-act https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-prem14a https://stock.noler.com/us/stock/sierra-oncology-inc/sec-filings-regdex https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/sierra-oncology-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/sierra-oncology-inc/share-price https://stock.noler.com/us/stock/sierra-oncology-inc/shareholders-equity https://stock.noler.com/us/stock/sierra-oncology-inc/shares-authorized https://stock.noler.com/us/stock/sierra-oncology-inc/shares-issued https://stock.noler.com/us/stock/sierra-oncology-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/sierra-oncology-inc/short-term-lease-cost https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/sierra-oncology-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/sierra-oncology-inc/stock-based-compensation https://stock.noler.com/us/stock/sierra-oncology-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/sierra-oncology-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sierra-oncology-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/sierra-oncology-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sierra-oncology-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sierra-oncology-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/sierra-oncology-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sierra-oncology-inc/stock-split-ratio https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/sierra-oncology-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-aggregate-amount-of-redemption-requirement https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/sierra-oncology-inc/temporary-equity-shares-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/sierra-oncology-inc/total-assets https://stock.noler.com/us/stock/sierra-oncology-inc/total-liabilities https://stock.noler.com/us/stock/sierra-oncology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sierra-oncology-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sierra-oncology-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/sierra-oncology-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/sierra-oncology-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/sierra-oncology-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/sierra-oncology-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/sierra-oncology-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sierra-oncology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted